A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
U S PHYSICAL THERAPY INC /NV
USPH
$2.1B
Mkt Cap
$74.58
+2.21%
U S PHYSICAL THERAPY INC /NV (USPH) has a current P/E ratio of 52.5, compared to its historical median P/E of 43.9. The stock is currently considered Fair based on its historical valuation range.
U S PHYSICAL THERAPY INC /NV (USPH) has a 5-year average return on invested capital (ROIC) of 8.9%. This is below average and may indicate limited pricing power.
U S PHYSICAL THERAPY INC /NV (USPH) has a market capitalization of $2.1B. It is classified as a mid-cap stock.
Yes, U S PHYSICAL THERAPY INC /NV (USPH) pays a dividend with a trailing twelve-month yield of 1.32%. The company also returns capital through share buybacks, with a buyback yield of 0.27%.
Based on historical P/E analysis, U S PHYSICAL THERAPY INC /NV (USPH) appears fair. The current P/E of 52.5 is 20% above its historical median of 43.9. The estimated fair value CAGR (P/E method) is -5.2%.
U S PHYSICAL THERAPY INC /NV (USPH) operates in the Services-Health Services industry, within the Healthcare sector.
U.S. Physical Therapy, Inc. through its subsidiaries (“we”, “us”, “our”, or the “Company”), operates its business through two reportable business segments. Our physical therapy operations segment consists of physical therapy, speech therapy and occupational therapy clinics and home-care physical and speech therapy practices that provide pre- and post-operative care and treatment for a variety of orthopedic-related disorders, sports-related injuries, and rehabilitation of injured workers. Services provided by the industrial injury prevention services (“IIP”) segment include onsite services for clients’ employees including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations and ergonomic assessments. The majority of IIP is contracted with and paid for directly by employers, including a number of Fortune 500 companies.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 781M | 781M | 671M | 605M | 553M | 495M |
| Net Income | 40M | 40M | 31M | 28M | 32M | 41M |
| EPS | $1.42 | $1.42 | $1.84 | $1.28 | $2.25 | $2.41 |
| Free Cash Flow | 61M | 61M | 66M | 73M | 50M | 68M |
| ROIC | 7.3% | 9.2% | 7.8% | 7.0% | 8.0% | 12.6% |
| Gross Margin | 19.2% | 19.2% | 18.5% | 20.1% | 20.3% | 23.7% |
| Debt/Equity | 0.73 | 0.73 | 0.63 | 0.54 | 1.03 | 1.14 |
| Dividends/Share | $0.98 | $0.98 | $1.76 | $1.09 | $1.64 | $1.46 |
| Operating Income | 87M | 87M | 63M | 51M | 57M | 71M |
| Operating Margin | 11.1% | 11.1% | 9.4% | 8.4% | 10.3% | 14.3% |
| ROE | 8.3% | 8.2% | 6.5% | 7.1% | 10.5% | 14.3% |
| Shares Outstanding | 28M | 28M | 17M | 22M | 14M | 17M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 305M | 331M | 357M | 414M | 454M | 482M | 423M | 495M | 553M | 605M | 671M | 781M | 781M |
| Gross Margin | 25.0% | 23.7% | 23.0% | 21.9% | 22.4% | 23.3% | 22.3% | 23.7% | 20.3% | 20.1% | 18.5% | 19.2% | 19.2% |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | 30M | 31M | 32M | 36M | 41M | 45M | 42M | 47M | 46M | 52M | 58M | 69M | 69M |
| EBIT | 46M | 47M | 50M | 55M | 60M | 67M | 52M | 71M | 57M | 51M | 63M | 87M | 87M |
| Op. Margin | 15.0% | 14.3% | 13.9% | 13.2% | 13.3% | 14.0% | 12.4% | 14.3% | 10.3% | 8.4% | 9.4% | 11.1% | 11.1% |
| Net Income | 25M | 26M | 26M | 27M | 35M | 40M | 35M | 41M | 32M | 28M | 31M | 40M | 40M |
| Net Margin | 8.3% | 8.0% | 7.4% | 6.6% | 7.7% | 8.3% | 8.3% | 8.2% | 5.8% | 4.7% | 4.7% | 5.1% | 5.1% |
| Non-Recurring | 169K | 211K | 131K | 599K | 9K | 25K | 2.1M | 30K | 9.8M | 16M | -836K | 100K | 100K |
| Returns on Capital | |||||||||||||
| ROIC | 15.2% | 13.9% | 13.3% | 16.0% | 17.2% | 16.2% | 12.3% | 12.6% | 8.0% | 7.0% | 7.8% | 9.2% | 7.3% |
| ROE | 18.4% | 16.7% | 14.7% | 14.0% | 16.6% | 17.6% | 13.6% | 14.3% | 10.5% | 7.1% | 6.5% | 8.2% | 8.3% |
| ROA | 10.8% | 9.7% | 8.0% | 7.1% | 8.1% | 7.5% | 5.7% | 6.1% | 4.0% | 3.0% | 2.9% | 3.3% | 3.3% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | 45M | 38M | 51M | 57M | 73M | 62M | 100M | 76M | 59M | 82M | 75M | 75M | 75M |
| Free Cash Flow | 40M | 31M | 43M | 49M | 66M | 52M | 92M | 68M | 50M | 73M | 66M | 61M | 61M |
| Owner Earnings | 35M | 25M | 37M | 42M | 57M | 45M | 82M | 57M | 37M | 59M | 48M | 44M | 44M |
| CapEx | 5.2M | 6.3M | 8.3M | 7.1M | 7.2M | 10M | 7.6M | 8.2M | 8.2M | 9.3M | 9.2M | 14M | 14M |
| Maint. CapEx | 6.7M | 8.0M | 8.8M | 9.7M | 9.8M | 10M | 11M | 12M | 15M | 16M | 19M | 22M | 22M |
| Growth CapEx | 0 | 0 | 0 | 0 | 0 | 94K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| D&A | 6.7M | 8.0M | 8.8M | 9.7M | 9.8M | 10M | 11M | 12M | 15M | 16M | 19M | 22M | 22M |
| CapEx/OCF | 11.4% | 16.7% | 16.2% | 12.6% | 9.9% | 16.3% | 7.6% | 10.7% | 14.1% | 11.3% | 12.3% | 18.7% | 18.7% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 5.9M | 7.4M | 8.5M | 10M | 12M | 15M | 4.1M | 19M | 21M | 24M | 27M | 27M | 27M |
| Dividend Yield | 1.3% | 1.2% | 1.1% | 1.1% | 1.0% | 0.8% | 0.3% | 1.1% | 1.7% | 1.2% | 1.7% | 1.2% | 1.3% |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.6M | 5.6M |
| Buyback Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.2% | 0.3% |
| Stock-Based Comp | 3.4M | 4.5M | 5.0M | 5.0M | 5.9M | 7.0M | 7.9M | 7.9M | 7.3M | 7.2M | 7.8M | 8.3M | 8.3M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.9M | 3.8M | 3.8M | 9.4M | 9.4M |
| Balance Sheet | |||||||||||||
| Net Debt | 56M | 77M | 78M | 93M | 54M | 160M | 94M | 309M | 295M | 106M | 265M | 310M | 310M |
| Cash & Equiv. | 14M | 16M | 20M | 22M | 23M | 24M | 33M | 29M | 32M | 153M | 41M | 36M | 36M |
| Long-Term Debt | 35M | 48M | 51M | 57M | 38M | 50M | 17M | 118M | 176M | 139M | 143M | 153M | 153M |
| Debt/Equity | 0.48 | 0.54 | 0.52 | 0.56 | 0.36 | 0.77 | 0.46 | 1.14 | 1.03 | 0.54 | 0.63 | 0.73 | 0.73 |
| Interest Coverage | 6.1 | 6.5 | 4.3 | 2.6 | 29.5 | 32.4 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Equity | 146M | 171M | 188M | 205M | 216M | 240M | 276M | 296M | 316M | 476M | 489M | 476M | 476M |
| Total Assets | 245M | 304M | 351M | 419M | 443M | 631M | 594M | 749M | 858M | 997M | 1.2B | 1.2B | 1.2B |
| Total Liabilities | 70M | 131M | 163M | 110M | 92M | 181M | 184M | 297M | 374M | 345M | 408M | 434M | 434M |
| Intangibles | 25M | 30M | 38M | 49M | 49M | 53M | 56M | 86M | 109M | 110M | 179M | 173M | 173M |
| Retained Earnings | 134M | 138M | 150M | 162M | 167M | 184M | 212M | 224M | 233M | 224M | 227M | 227M | 227M |
| Working Capital | 29M | 41M | 41M | 38M | 37M | 25M | -5.9M | 12M | 26M | 131M | 21M | 950K | 950K |
| Current Assets | 55M | 60M | 66M | 77M | 79M | 85M | 88M | 95M | 111M | 233M | 138M | 140M | 140M |
| Current Liabilities | 26M | 19M | 25M | 40M | 42M | 61M | 93M | 83M | 85M | 102M | 116M | 139M | 139M |
| Per Share Data | |||||||||||||
| EPS | 1.62 | 1.77 | 1.64 | 1.76 | 2.75 | 2.45 | 2.48 | 2.41 | 2.25 | 1.28 | 1.84 | 1.42 | 1.42 |
| Owner EPS | 2.25 | 1.68 | 2.33 | 2.68 | 4.52 | 2.78 | 5.75 | 3.36 | 2.56 | 2.68 | 2.84 | 1.59 | 1.59 |
| Book Value | 9.36 | 11.43 | 11.71 | 13.12 | 17.02 | 14.70 | 19.46 | 17.45 | 22.10 | 21.58 | 28.63 | 17.09 | 17.09 |
| Cash Flow/Share | 2.89 | 2.51 | 3.19 | 3.62 | 5.76 | 3.82 | 7.05 | 4.51 | 4.10 | 3.72 | 4.39 | 2.69 | 2.22 |
| Dividends/Share | 0.48 | 0.60 | 0.68 | 0.80 | 0.92 | 1.14 | 0.32 | 1.46 | 1.64 | 1.09 | 1.76 | 0.98 | 0.98 |
| Shares Out. | 15.6M | 15.0M | 16.0M | 15.6M | 12.7M | 16.3M | 14.2M | 16.9M | 14.3M | 22.1M | 17.1M | 27.9M | 27.9M |
| Valuation | |||||||||||||
| P/E Ratio | 22.4 | 26.9 | 38.4 | 36.5 | 70.3 | 42.3 | 45.4 | 37.7 | 32.8 | 71.2 | 48.2 | 57.0 | 52.5 |
| P/FCF | 14.2 | 22.8 | 23.6 | 20.3 | 17.8 | 32.4 | 17.3 | 22.6 | 21.0 | 27.7 | 23.1 | 37.0 | 34.1 |
| EV/EBIT | 13.6 | 16.7 | 22.0 | 20.0 | 20.3 | 24.5 | 29.5 | 21.1 | 17.9 | 33.2 | 23.3 | 25.6 | 27.6 |
| Price/Book | 3.9 | 4.2 | 5.4 | 4.9 | 5.4 | 7.1 | 5.8 | 5.2 | 3.3 | 4.2 | 3.1 | 4.7 | 4.4 |
| Price/Sales | N/A | 1.9 | 2.3 | 2.2 | 2.5 | 3.7 | 2.8 | 3.6 | 2.3 | 3.4 | 2.3 | 2.8 | 2.7 |
| FCF Yield | 7.1% | 4.4% | 4.2% | 4.9% | 5.6% | 3.1% | 5.8% | 4.4% | 4.8% | 3.6% | 4.3% | 2.7% | 2.9% |
| Market Cap | 567M | 713M | 1.0B | 1.0B | 1.2B | 1.7B | 1.6B | 1.5B | 1.1B | 2.0B | 1.5B | 2.3B | 2.1B |
| Avg. Price | 29.93 | 41.50 | 50.32 | 58.51 | 88.40 | 108.08 | 83.14 | 104.29 | 89.09 | 94.45 | 91.49 | 78.77 | 74.58 |
| Year-End Price | 36.30 | 47.67 | 63.06 | 64.20 | 92.11 | 103.75 | 112.52 | 90.94 | 73.91 | 91.13 | 88.77 | 81.00 | 74.58 |
U S PHYSICAL THERAPY INC /NV passes 2 of 9 quality checks, indicating weak fundamentals.
U S PHYSICAL THERAPY INC /NV trades at 52.5x trailing earnings, compared to its 15-year median P/E of 43.9x, suggesting it is currently Fair relative to its historical range. On a free-cash-flow basis, the stock trades at 18.5x vs a median of 22.8x. The company's 5-year average ROIC is 8.9% with a gross margin of 20.3%. Total shareholder yield (dividends + buybacks) is 1.6%. At current prices, the estimated annualized return to fair value is -2.5%.
U S PHYSICAL THERAPY INC /NV (USPH) reported annual revenue of $781 million in its most recent fiscal year, based on SEC EDGAR filings.
U S PHYSICAL THERAPY INC /NV (USPH) has a net profit margin of 5.1%. This is a modest margin.
U S PHYSICAL THERAPY INC /NV (USPH) generated $61 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
U S PHYSICAL THERAPY INC /NV (USPH) has a debt-to-equity ratio of 0.73. This indicates moderate leverage.
U S PHYSICAL THERAPY INC /NV (USPH) reported earnings per share (EPS) of $1.42 in its most recent fiscal year.
U S PHYSICAL THERAPY INC /NV (USPH) has a return on equity (ROE) of 8.2%. This indicates moderate shareholder returns.
U S PHYSICAL THERAPY INC /NV (USPH) has a 5-year average gross margin of 20.3%. This lower margin is typical of capital-intensive or commodity businesses.
The Ledger Terminal provides 17 years of financial data for U S PHYSICAL THERAPY INC /NV (USPH), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
U S PHYSICAL THERAPY INC /NV (USPH) has a book value per share of $17.09, based on its most recent annual SEC filing.
No recent press releases.